R

Rapport Therapeutics

Develops precision neuromedicines for brain disorders

Associate Director - New Product Planning

Business AnalysisConfirmed live in the last 24 hours
Full-timeBoston, MA, USA$205k - $225k

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 5 years of relevant experience in pharmaceutical or biotechnology commercial strategy, new product planning, or life sciences management consulting.
  • Demonstrated expertise building and defending complex forecasting models; Excel-based modeling is required, while familiarity with forecasting software is a plus.
  • A strong track record leading or contributing to commercial opportunity assessments, market sizing, and competitive intelligence analyses.
  • Strong analytical, quantitative, and financial modeling skills.
  • Ability to communicate complex data clearly to senior leadership.
  • Experience working cross-functionally across Research and Development, Medical, Commercial, and Finance.
  • Ability to travel approximately 20% or more depending on business needs, including congress attendance.

Responsibilities

  • Build, maintain, and continuously refine multi-year commercial forecasts for pipeline assets across multiple indications and geographies, using epidemiology-based and analog-based approaches.
  • Develop patient flow, market share, and pricing and access models to support investment decisions, licensing evaluations, and portfolio prioritization.
  • Stress-test forecast assumptions through sensitivity analyses and scenario planning, and communicate key drivers, risks, and uncertainty ranges.
  • Lead end-to-end opportunity assessments for early- and mid-stage pipeline assets, including market sizing, competitive landscape analysis, unmet need evaluation, and target product profile development through primary and desktop research.
  • Manage primary market research involving physicians, patients, and payers to inform positioning and forecast assumptions, and manage relationships with external vendors and consultants.
  • Partner with Discovery, Medical, Clinical Development, Regulatory, and Market Access to evaluate indication sequencing, target population definition, and differentiation strategy.
  • Synthesize primary and secondary market research, including key opinion leader interviews, payer and provider surveys, and syndicated data, into quantitative and qualitative outputs that guide investment and program-level decisions.
  • Support in-licensing, out-licensing, and mergers and acquisitions due diligence with commercial assessments and valuation inputs.
  • Prepare materials for governance forums, including portfolio reviews, program committees, and board updates, presenting analyses in a clear, concise, decision-ready format.
  • Contribute to long-range portfolio planning, identify lifecycle opportunities, and inform research and development prioritization; serve as a subject matter expert on market dynamics, target product profiles, and associated revenue opportunities for assigned programs.
  • Partner with Research and Development program teams to provide commercial input into program-level decision models, including go/no-go criteria, indication sequencing, trial design trade-offs, and target product profile refinement, ensuring commercial assumptions and market realities are reflected in development strategy.
  • Represent the commercial perspective on program teams and governance forums, translating clinical development scenarios into commercial implications such as revenue impact, competitive positioning, and market access considerations to inform research and development investment decisions.
  • Serve as a thought partner to Discovery, Development, Finance, and future Commercial teams throughout asset lifecycle planning.

Desired Qualifications

  • A Master of Business Administration, Master of Public Health, or advanced life sciences degree is a plus.
  • Familiarity with forecasting software is a plus.
  • Life sciences consulting experience, such as strategy consulting, commercial due diligence, or pharma-focused advisory, is strongly preferred.
  • Therapeutic area experience in neurology and/or psychiatry is a plus.

About the Company

Rapport Therapeutics

Develops precision neuromedicines for brain disorders

Rapport Therapeutics develops precision neuromedicines for neurological disorders. The company focuses on discovering and developing drugs that act only in disease-relevant areas of the brain to reduce symptoms with fewer side effects. Their discovery platform uses region-specific RAPs (Receptor Associated Proteins) to guide drug targeting to specific brain cells or regions, aiming to improve patient benefit. Unlike many peers, Rapport emphasizes selective targeting through RAPs and relies on experienced leadership to drive science and partnerships, with revenue from developing and potentially running clinical trials and related services. The goal is to provide treatments for drug-resistant epilepsies and mood disorders by delivering therapies that are active only where needed in the brain, reducing unwanted effects and improving outcomes.

Company size
51-200
Company stage
IPO
Headquarters
Boston, MA
Founded
2022

Recently Posted Jobs

Explore more opportunities at Rapport Therapeutics

See more jobs